Closing in on the Puzzle of ONJ

Editorial

Michael Glick. J Am Dent Assoc. 2008 Jan.

. 2008 Jan;139(1):12, 14-5.

doi: 10.14219/jada.archive.2008.0002.

No abstract available

Comment on

Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people.
Cartsos VM, Zhu S, Zavras AI. Cartsos VM, et al. J Am Dent Assoc. 2008 Jan;139(1):23-30. doi: 10.14219/jada.archive.2008.0016. J Am Dent Assoc. 2008. PMID: 18167381
Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.
Grbic JT, Landesberg R, Lin SQ, Mesenbrink P, Reid IR, Leung PC, Casas N, Recknor CP, Hua Y, Delmas PD, Eriksen EF; Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly Pivotal Fracture Trial Research Group. Grbic JT, et al. J Am Dent Assoc. 2008 Jan;139(1):32-40. doi: 10.14219/jada.archive.2008.0017. J Am Dent Assoc. 2008. PMID: 18167382 Clinical Trial.